Summary
HCA Healthcare, Inc. reported a solid second quarter for 2023, with revenues increasing by 7.0% to $15.861 billion compared to the same period in 2022. Net income attributable to HCA Healthcare, Inc. also saw a modest increase, reaching $1.193 billion, or $4.29 per diluted share. This growth was driven by a combination of increased patient volumes, evidenced by a 4.0% rise in equivalent admissions, and a 2.9% increase in revenue per equivalent admission. The company continues to manage its cost structure effectively, with salaries and benefits remaining relatively stable as a percentage of revenue, though other operating expenses, particularly professional fees, saw an increase. Cash flows from operations showed significant strength, increasing by $845 million year-over-year, largely due to positive changes in working capital. Despite economic uncertainties and inflationary pressures, HCA demonstrated resilience. The company experienced a decline in uninsured admissions, which is a positive sign for revenue collection. Management expects to fund significant capital expenditures, projected at $4.7 billion for 2023, through a combination of operational cash flow and debt. A notable event during the quarter was a data security incident announced in July 2023, involving patient information for approximately 11 million individuals. While the investigation is ongoing, HCA stated it does not believe this incident will materially impact its business or financial results.
Financial Highlights
46 data points| Revenue | $15.86B |
| Operating Expenses | $14.05B |
| Interest Expense | $485.00M |
| Net Income | $1.19B |
| EPS (Basic) | $4.35 |
| EPS (Diluted) | $4.29 |
| Shares Outstanding (Basic) | 274.49M |
| Shares Outstanding (Diluted) | 278.20M |
Key Highlights
- 1Second quarter 2023 revenues rose 7.0% to $15.861 billion, driven by increased patient volumes and higher revenue per admission.
- 2Net income attributable to HCA Healthcare, Inc. was $1.193 billion, or $4.29 per diluted share, up from $1.155 billion in Q2 2022.
- 3Consolidated equivalent admissions increased by 4.0% and revenue per equivalent admission grew by 2.9% year-over-year.
- 4Cash flow from operations significantly improved, increasing by $845 million to $2.475 billion for the quarter.
- 5Uninsured admissions continued to decline, with same facility uninsured admissions down 6.6% compared to Q2 2022.
- 6The company announced a data security incident affecting approximately 11 million patients, though it does not expect a material financial impact.
- 7Planned capital expenditures for 2023 are expected to be around $4.7 billion, with significant ongoing projects.